Ipg Investment Advisors LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Ipg Investment Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$0.63 - $0.96 $36,152 - $55,089	57,385 New	57,385 $45,000
Q2 2021 Aug 13, 2021	SELL	$0.75 - $1.1 $24,288 - $35,623	-32,385 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$0.96 - $1.74 $21,489 - $38,949	22,385 Added 223.85%	32,385 $34 Million
Q2 2019 Aug 12, 2019	SELL	$0.79 - $1.11 $25,675 - $36,075	-32,500 Reduced 76.47%	10,000 $8.57 Million
Q1 2019 May 10, 2019	BUY	$0.6 - $1.41 $9,000 - $21,150	15,000 Added 54.55%	42,500 $46.3 Million
Q4 2018 Feb 01, 2019	BUY	$0.53 - $1.11 $14,575 - $30,525	27,500 New	27,500 $16.4 Million
Q4 2017 Feb 07, 2018	SELL	$1.1 - $1.54 $48,950 - $68,530	-44,500 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$1.19 - $1.43 $52,955 - $63,635	44,500	44,500 $58.7 Million

2.74M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $143M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Ipg Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Ipg Investment Advisors LLC with notifications on news.